obesity

Engineered viruses target gut bacteria to deliver drugs for inflammation and obesity

Phages could be used as a drug delivery system for conditions such as inflammation and obesity.

Bloom Science’s Live Biotherapeutic BL-001 achieves significant weight loss in Phase 1 trial

Positive results from Phase 1 trial of BL-001, an innovative live biotherapeutic product (LBP) designed to replicate the metabolic effects of the ketogenic diet.

Understanding the physiology of hunger: an exclusive interview with Alessio Fasano

The discussion with Professor Alessio Fasano highlights the complex interplay between homeostatic, hedonic, and microbiota-driven mechanisms in regulating hunger.

New study challenges link between early-life gut microbiota and obesity risk

The findings suggest that the composition of the gut microbiota in early life is not a key factor in obesity risk.

Gut bacteria may increase obesity risk by influencing fat metabolism

A recent study highlights the role of specific obesogenic microbes suggesting potential interventions through targeted regulation of M. rupellensis and myo-inositol metabolism.

A high-fat diet promotes breast cancer by altering gut microbial metabolism

The findings of a recent study suggest that Desulfovibrio can drive cancer progression, paving the way for therapeutic approached that targeting the gut microbiota.

The cloudy link between gut microbes and obesity

Although a causative relationship between obesity and gut microbes remains unclear, microbiota-based treatments may help to combat obesity.

Mice study hints at how gut microbes may protect from childhood obesity

The findings of a recent study suggest that the microbiota-derived metabolite phenyllactic acid can prevent antibiotic-associated obesity in early life.

Unlocking the potential of probiotics: genetically engineering Saccharomyces boulardii for effective obesity management

Karl Alex Hedin (Technical University of Denmark) talks about the potential role of genetically engineering Saccharomyces boulardii to produce an anti-obesity peptide.

Microbiota transplant after gastric bypass improves metabolism in mice

The findings of a recent study suggest that the gut microbiota contributes to improve metabolic health after gastric bypass surgery.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top